Ruksha Pinda Sweda in the Management of Multiple joint pain

Phase 3

Recruiting

• Conditions: Rheumatoid arthritis, unspecified. Ayurveda Condition: AMAVATAH,

• Registration Number: CTRI/2023/11/060355
• Lead Sponsor: DR PRATHAMESH UMAKANT PANDEY

Brief Summary

Amavata, as described in Ayurveda, is a condition resulting from factors like an incompatible diet, weak digestion, and a sedentary lifestyle, exacerbated by indulgence in unctuous foods and exercise. Ama, a product of incomplete metabolism, accumulates in the body and is driven by vitiated Vata to affect various areas, leading to symptoms like body pain, loss of appetite, fatigue, and joint-related issues. Rheumatoid Arthritis (RA) is a systemic autoimmune disease primarily impacting joints, causing symmetrical arthritis, cartilage and bone damage. It affects approximately 1% of the world’s population, with a higher prevalence in women. Management is complex, involving medication, dietary control, and lifestyle changes, but internal medications may not always provide optimal results. In Ayurveda, Amavata is treated with therapeutic techniques like Swedana, Langhana, and herbal preparations like Tikta-Katu Deepana. Swedana, which uses specific heated medicines, enhances metabolic activity, a key aspect of Amavata management. Ruksha Pinda Sweda, involving dry heated boluses, is commonly used, with Valuka Sweda as an ancillary treatment. A comparative study explores alternative therapies like Karisha and Ayas Pinda Sweda’s efficacy for Amavata. Both systems, Ayurveda and modern medicine, address joint-related conditions, offering holistic and integrated approaches to improve the quality of life for those affected.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-10-12
• Last Update Posted: 2024-07-19

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Patients fulfilling diagnostic criteria.
• Participants satisfying 2010 ACR EULAR classification criteria for rheumatoid arthritis.
• Patients having a clinical presentation of Amavata.

Exclusion Criteria

• Patients with major systemic illnesses like cardiac disease, uncontrolled hypertension, kidney disease, and uncontrolled diabetes mellitus.
• Those who have undergone surgical treatment in affected joints.
• Patients who report any untoward symptoms during the period of study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
VAS scale, 2010 ACR EULAR classification criteria for Rheumatoid Arthritis, ROM by Goniometer	1,7 & 14 Day

Secondary Outcome Measures

Name	Time	Method
Anthropometric measurement of big joints by measuring tape & Jeweler’s ring sizer	measurement for small joints.

Trial Locations

Locations (1)

S G PATEL AYURVEDA HOSPITAL & MATERNITY HOME; 🇮🇳 Anand, GUJARAT, India

S G PATEL AYURVEDA HOSPITAL & MATERNITY HOME

🇮🇳Anand, GUJARAT, India

DR PRATHAMESH UMAKANT PANDEY

Principal investigator

9833372948

prathameshpandey@gmail.com